Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02342236
Other study ID # 06101968-3
Secondary ID
Status Completed
Phase N/A
First received January 5, 2015
Last updated September 12, 2016
Start date June 2014
Est. completion date December 2015

Study information

Verified date September 2016
Source Military Institute of Medicine, Poland
Contact n/a
Is FDA regulated No
Health authority Poland: Ethics Committee
Study type Interventional

Clinical Trial Summary

Postoperative Cognitive Disorders (POCD) are common in hospitalized people > 60 year old, especially in orthopedic patients. Etiology of POCD is complex, and in some aspects still remains unclear. The role of thromboembolic events in etiology of POCD was discussed. The incidence of such events in patients who underwent big joints arthroplasty can be as high as 40 to 60%, although some cases are subclinical. Thromboembolic material can block a blood flow through a vessels in the brain. As a consequence cerebral neurons can be damaged or destroyed. After neuronal damage specific substances, such as S100B protein, glial fibrillary acidic protein (GFAP) and neuron-specific enolase (NSE) are released to the blood. The serum concentrations of these biomarkers can be measured. Moreover, the block of blood flow will decrease regional cerebral saturation in affected parts of the brain.

In this project the authors would like to analyze the correlation between the regional cerebral saturation and serum concentration of both S100B protein and GFAP in orthopedic patients scheduled to primary hip arthroplasty.


Recruitment information / eligibility

Status Completed
Enrollment 18
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patient scheduled to primary hip arthroplasty,

- orthopedic procedure under spinal anesthesia.

Exclusion Criteria:

- patients younger than 18 y.o.,

- surgery under general anesthesia,

- patients who refused to participate in the study.

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Device:
cemented or cementless type of hip prothesis


Locations

Country Name City State
Poland Department of Anesthesiology and Intensive Therapy Warsaw

Sponsors (1)

Lead Sponsor Collaborator
Military Institute of Medicine, Poland

Country where clinical trial is conducted

Poland, 

References & Publications (6)

Colonna DM, Kilgus D, Brown W, Challa V, Stump DA, Moody DM. Acute brain fat embolization occurring after total hip arthroplasty in the absence of a patent foramen ovale. Anesthesiology. 2002 Apr;96(4):1027-9. — View Citation

Monk TG, Weldon BC, Garvan CW, Dede DE, van der Aa MT, Heilman KM, Gravenstein JS. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology. 2008 Jan;108(1):18-30. — View Citation

Nylén K, Csajbok LZ, Ost M, Rashid A, Blennow K, Nellgård B, Rosengren L. Serum glial fibrillary acidic protein is related to focal brain injury and outcome after aneurysmal subarachnoid hemorrhage. Stroke. 2007 May;38(5):1489-94. Epub 2007 Mar 29. — View Citation

Slater JP, Guarino T, Stack J, Vinod K, Bustami RT, Brown JM 3rd, Rodriguez AL, Magovern CJ, Zaubler T, Freundlich K, Parr GV. Cerebral oxygen desaturation predicts cognitive decline and longer hospital stay after cardiac surgery. Ann Thorac Surg. 2009 Jan;87(1):36-44; discussion 44-5. doi: 10.1016/j.athoracsur.2008.08.070. — View Citation

Vos PE, Jacobs B, Andriessen TM, Lamers KJ, Borm GF, Beems T, Edwards M, Rosmalen CF, Vissers JL. GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study. Neurology. 2010 Nov 16;75(20):1786-93. doi: 10.1212/WNL.0b013e3181fd62d2. — View Citation

Wiesmann M, Steinmeier E, Magerkurth O, Linn J, Gottmann D, Missler U. Outcome prediction in traumatic brain injury: comparison of neurological status, CT findings, and blood levels of S100B and GFAP. Acta Neurol Scand. 2010 Mar;121(3):178-85. doi: 10.1111/j.1600-0404.2009.01196.x. Epub 2009 Oct 5. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in regional cerebral oxygen during primary hip arthroplasty The analysis of regional cerebral oxygen saturation will start just before the anesthesia and ends just after the surgery. Duration of the orthopedic procedure, an expected average of 2 hours. No
Secondary Changes in serum levels of S100B protein from baseline at 72 hours after the surgery The serum concentration of S100B protein will be measured [1] just before the surgery, [2] just after the end of the surgery, an expected average of two hours, [3] 6 hours after the beginning of the surgery, [4] 24 hours after the beginning of the surgery, and [5] 72 hours after the beginning of the surgery. 72 hours No
Secondary Changes in serum levels of GFAP from baseline at 72 hours after the surgery The serum concentration of GFAP protein will be measured [1] just before the surgery, [2] just after the end of the surgery, an expected average of two hours, [3] 6 hours after the beginning of the surgery, [4] 24 hours after the beginning of the surgery, and [5] 72 hours after the beginning of the surgery. 72 hours No
See also
  Status Clinical Trial Phase
Terminated NCT02489097 - International Substudy Enigma2 on Postoperative Cognitive Disorders Phase 4
Terminated NCT00757913 - n-3 Enriched Nutrition Therapy and Postoperative Cognitive Dysfunction After Cardiac Surgery Phase 4
Completed NCT00212147 - Interaction of Cobalamin Status With Nitrous Oxide in Relation to Postoperative Cognitive Changes in the Elderly N/A
Completed NCT01951118 - Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly Phase 4
Completed NCT02324153 - Ramelteon in the Prevention of Post-operative Delirium Phase 2
Completed NCT02957123 - Intranasal Inhalations of Bioactive Factors Produced by M2 Macrophages in Patients With Organic Brain Syndrome Phase 1/Phase 2
Recruiting NCT01696591 - The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD N/A
Completed NCT00512200 - Postoperative Cognitive Dysfunction in Geriatric Patients N/A
Completed NCT00294307 - Enhancing Care Coordination: Hospital to Home for Cognitively Impaired Older Adults and Their Caregivers
Completed NCT03938870 - CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease
Completed NCT00402311 - The Effects and Cost-Effectiveness of an Integrated Multidisciplinary Approach for Psychogeriatric Patients N/A